Patent assignee · US · COMPANY

Sarepta Therapeutics, Inc.

🏢 View company profile →
123Patents
122Active
123Granted
60Portfolio score

Filing activity: May 10, 2006 → Apr 6, 2023 · 12 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8865883B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 89 Active
US8501703B2 Chimeric oligomeric compounds for modulation of splicing Chemistry; Metallurgy 87 Active
US9416361B2 Splice-region antisense composition and method Chemistry; Metallurgy 86 Active
US8895722B2 Splice-region antisense composition and method Chemistry; Metallurgy 84 Active
US8835402B2 Compound and method for treating myotonic dystrophy Chemistry; Metallurgy 78 Active
US8871918B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 64 Active
US9506058B2 Compositions for treating muscular dystrophy Chemistry; Metallurgy 59 Active
US8779128B2 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups Emerging Cross-Sectional Technologies 58 Active
US8741863B2 Compound and method for treating myotonic dystrophy Chemistry; Metallurgy 54 Active
US9447417B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 52 Active
US9434948B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 51 Active
US8877725B2 Peptide conjugated, inosine-substituted antisense oligomer compound and method Chemistry; Metallurgy 48 Active
US8536147B2 Antibacterial antisense oligonucleotide and method Chemistry; Metallurgy 47 Active
US8785410B2 Antisense composition and method for treating muscle atrophy Emerging Cross-Sectional Technologies 43 Active
US10337003B2 Compositions for treating muscular dystrophy Chemistry; Metallurgy 41 Active
US9217148B2 Exon skipping compositions for treating muscular dystrophy Emerging Cross-Sectional Technologies 41 Active
US8697858B2 Antisense antiviral compound and method for treating influenza viral infection Chemistry; Metallurgy 39 Active
US8785407B2 Antisense antiviral agent and method for treating ssRNA viral infection Human Necessities 38 Active
US8524676B2 Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds Emerging Cross-Sectional Technologies 38 Active
US8501704B2 Immunosuppression compound and treatment method Chemistry; Metallurgy 37 Active
US10364431B2 Compositions for treating muscular dystrophy Chemistry; Metallurgy 37 Active
US8906872B2 Antisense antiviral compound and method for treating ssRNA viral infection Emerging Cross-Sectional Technologies 36 Active
US8592386B2 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis Chemistry; Metallurgy 35 Active
US8618270B2 Oligonucleotide analog and method for treating flavivirus infections Emerging Cross-Sectional Technologies 35 Active
US9161948B2 Peptide oligonucleotide conjugates Chemistry; Metallurgy 35 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.